Skip to main content

An independent, nonpartisan information resource — not affiliated with the U.S. government, Senator Fetterman, or any campaign. Read about this project.

Wyden Amdt. No. 5336

April 23, 2026 · On the Amendment

Fetterman voted: Yea

Senator John Fetterman voted Yea on this measure. On this vote, Fetterman voted with the majority of the Senate Democratic caucus. The final result was Amendment Rejected (48–50).

What kind of vote this was

This was a vote on an amendment — a proposed change to the text of the underlying measure. Approval required a simple majority.

What this vote was about

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

How the parties split

CaucusYeaNay
Democrats440
Republicans250
Independents20

In total, 98 senators voted on this question. The question was decided by a margin of 2 votes. 2 senators did not vote. Senate Democrats split 44–0 and Republicans 2–50. Independents split 2–0. Fetterman’s Yea was one of 44 cast by Senate Democrats.

Primary source

U.S. Senate Roll Call Vote — 119th Congress, Session 2, Vote No. 103.

View the official record on Senate.gov

This vote in Fetterman’s record

This site groups the vote under Procedural & other votes. Across 417 votes in that cluster, Fetterman voted Yea 245 times and Nay 150 times, and broke with the Democratic caucus majority on 45 of them (10.8%).

Questions and answers

How did Fetterman vote on Wyden Amdt. No. 5336?
Senator John Fetterman voted Yea on Wyden Amdt. No. 5336 on April 23, 2026. The measure’s outcome was: Amendment Rejected.
Did Fetterman vote with his party on this?
Yes. On this vote Fetterman voted with the majority of Senate Democrats.

Related procedural & other votes